|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-7-8
|
|
pubmed:abstractText |
Membranous nephropathy (MN) is characterized by proteinuria and other symptoms of the nephrotic syndrome. In many cases, the etiology is unknown. Whether and how to treat MN is still a controversial question. Despite the use of corticosteroids and alkylating agents, up to 40% of patients still progress to end-stage renal failure.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0723-5003
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
519-24
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18604487-Adult,
pubmed-meshheading:18604487-Antibodies, Monoclonal,
pubmed-meshheading:18604487-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:18604487-Biopsy,
pubmed-meshheading:18604487-Drug Resistance,
pubmed-meshheading:18604487-Drug Therapy, Combination,
pubmed-meshheading:18604487-Glomerular Basement Membrane,
pubmed-meshheading:18604487-Glomerulonephritis, Membranous,
pubmed-meshheading:18604487-Humans,
pubmed-meshheading:18604487-Immunoglobulin A,
pubmed-meshheading:18604487-Immunologic Factors,
pubmed-meshheading:18604487-Immunosuppressive Agents,
pubmed-meshheading:18604487-Kidney Function Tests,
pubmed-meshheading:18604487-Kidney Glomerulus,
pubmed-meshheading:18604487-Male
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
[Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
|
|
pubmed:affiliation |
Klinik für Innere Medizin III, Klinikum der Friedrich-Schiller-Universität Jena, Jena. martin.busch@med.uni-jena.de
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
